The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1310
April 20, 2009
View Complete Issue         Table of Contents 2019 
Adapalene-Benzoyl Peroxide (Epiduo) for Acne
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Adapalene-Benzoyl Peroxide (Epiduo) for Acne
April 20, 2009 (Issue: 1310)
Epiduo gel (Galderma), a fixed-dose combination of adapalene 0.1% (Differin), a synthetic retinoid analog, and benzoyl peroxide (BPO) 2.5%, an oxidizing agent, has been approved by the FDA for topical treatment of acne vulgaris in patients ≥12...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Adapalene-Benzoyl Peroxide (Epiduo) for Acne
Article code: 1310b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.